Sharp Therapeutics Corp (SHRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 3,485 | 377 |
| TOTAL | $3,519 | $426 |
| Non-Current Assets | ||
| PPE Net | 1,018 | 1,104 |
| Other Non-Current Assets | 17 | 17 |
| TOTAL | $1,035 | $1,121 |
| Total Assets | $4,554 | $1,546 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | N/A | 5,887 |
| Accounts payable and accrued liabilities | 272 | 185 |
| Accrued Expenses | 230 | 210 |
| Other current liabilities | 131 | 1,393 |
| TOTAL | $690 | $7,720 |
| Non-Current Liabilities | ||
| Long Term Debt | N/A | 1,188 |
| Other Non-Current Liabilities | 0 | 2,805 |
| TOTAL | $1,279 | $5,309 |
| Total Liabilities | $1,969 | $13,029 |
| Shareholders' Equity | ||
| Common Shares | 21,791 | 4,550 |
| Retained earnings | -19,885 | -16,624 |
| Other shareholders' equity | 6 | 0 |
| TOTAL | $2,585 | $-11,482 |
| Total Liabilities And Equity | $4,554 | $1,546 |